Official UK procurement notice
AI for Skin Cancer Detection
Authority: Bradford Teaching Hospitals NHS Foundation Trust (Central government)
What is being bought
Published requirement descriptionProvision of autonomous AI software for skin cancer diagnosis.
The lotProcurement structure
single lot · no lot value publishedProcedure terms & legal framework
From the official record- Procedure method
- Direct award
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 26 Jan 2026, 10:40 GMT
- Last source update
- 30 Jul 2026, 15:32 BST
- Authority reference
BTH25-319- FTS notice number
2026/S 000-072305- Latest notice
- Contract details notice (UK7)
- Delivery area
- Not published
- Official registry OCID
ocds-h6vhtk-060e15Find a Tender
- Why no open competition
- Single Suppliers Technical Reasons
- Published justification
The Musculoskeletal, Plastics, Breast, and Skin Team at Bradford Teaching Hospitals NHS Foundation Trust (BTHFT) has identified the need for autonomous AI software to aid with skin cancer detection.
A compliant route to market was identified as a direct award under the Procurement Act 2023.
NICE has conditionally recommended only one AI software for autonomous use for direct patient care in cancer pathways, for use in the NHS over a three-year period while further evidence is generated to confirm its clinical and cost-effectiveness. The software is called Deep Ensemble for Recognition of Malignancy (DERM). DERM, has a Class III CE mark and is manufactured by Skin Analytics.
The reasoning for a direct award is that DERM is the only AI solution with the requisite Class III CE mark and NICE conditional recommendation for autonomous use in the suspected skin cancer pathway. No alternative supplier can provide the necessary clearance and compliance for this pathway.
How it was run
Official notice- Submission deadline
- —
Timeline
9 Feb 2026 → 30 Jul 2026 · 2 dates- Standstill ends252 days ago9 Feb 2026, 23:59 GMT
- Notice published82 days ago30 Jul 2026, 15:32 BST
Notice history
4 events · 3 releases on Find a Tender · since 26 Jan 2026- Transparency notice published26 Jan 2026, 10:40 GMTUK5
- Contract award notice published29 Jan 2026, 10:34 GMTUK6
- Contract signature expected16 Feb 2026, 23:59 GMTscheduled
- Contract details notice published30 Jul 2026, 15:32 BSTUK7
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Skin Analytic Ltd1 Apr 2026 – 31 Mar 2029 · up to 31 Mar 2031Extensions: two extensions of 12 months each | £764,304same award published again · counted once | 29 Jan 2026standstill to 9 Feb 2026 | Standstill |
| Skin Analytic Ltd | £764,304 † | — | Awarded |
Contracts
AI for Skin Cancer Detection · Skin Analytic Ltd
- Signed
- 21 Mar 2026
- Value
- £764,304
- Period
- 1 Apr 2026 – 31 Mar 2029 · up to 31 Mar 2031 with extensions
- Status
- active
- Extensions
- two possible extensions of 12 months each
No agreed KPIs: Contract is for the supply of software, the clinical application of the software is being monitored outside of this contract
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- Skin Analytics LtdAwarded supplier
Official documents & specifications (3)
Official links; attachments are not copiedNotices published for this procedure
- Contract details notice Contract details notice on Find a Tender
- Contract award notice Contract award notice on Find a Tender
- Transparency notice Transparency notice on Find a Tender